Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasome Activation in Parkinson’s Disease
Shannon Jewell, Ashane M. Herath, Richard D. Gordon
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S113-S128
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

A Wonderful Journey: The Diverse Roles of Adenosine Deaminase Action on RNA 1 (ADAR1) in Central Nervous System Diseases
Lin Cheng, Ziying Liu, Chunxiao Shen, et al.
CNS Neuroscience & Therapeutics (2025) Vol. 31, Iss. 1
Open Access | Times Cited: 1
Glymphatic System Pathology and Neuroinflammation as Two Risk Factors of Neurodegeneration
Stanisław Szlufik, Kamila Kopeć, Stanisław Szleszkowski, et al.
Cells (2024) Vol. 13, Iss. 3, pp. 286-286
Open Access | Times Cited: 12
The Role of Epigenetics in Neuroinflammatory-Driven Diseases
Sebastiano Giallongo, Lucia Longhitano, Simona Denaro, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 15218-15218
Open Access | Times Cited: 33
Neuroinflammation is linked to dementia risk in Parkinson’s disease
Antonina Kouli, Lennart R. B. Spindler, Tim D. Fryer, et al.
Brain (2023) Vol. 147, Iss. 3, pp. 923-935
Open Access | Times Cited: 18
On the Chemical and Biological Characteristics of Multifunctional Compounds for the Treatment of Parkinson’s Disease
Olimpo García‐Beltrán, Pamela J. Urrutia, Marco T. Núñez
Antioxidants (2023) Vol. 12, Iss. 2, pp. 214-214
Open Access | Times Cited: 15
Resveratrol-Enhanced Human Neural Stem Cell-Derived Exosomes Mitigate MPP+-Induced Neurotoxicity Through Activation of AMPK and Nrf2 Pathways and Inhibition of the NLRP3 Inflammasome in SH-SY5Y Cells
Tony F. Chan, Yuping Yang, Christopher J.B. Nicol, et al.
Life (2025) Vol. 15, Iss. 2, pp. 294-294
Open Access
Serotype and distribution of adhesion genes in Streptococcus mutans isolated from people with Parkinson’s disease
Laura Donnet, Olivier Claisse, Johan Samot
Odontology (2025)
Closed Access
Pharmacologic inhibition of NLRP3 reduces the levels of α-synuclein and protects dopaminergic neurons in a model of Parkinson’s disease
Jesús Amo‐Aparicio, Jonathan Daly, Jesper Falkesgaard Højen, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Impact of sex on neuroimmune contributions to Parkinson’s disease
Mélanie Bourque, Marc Morissette, Denis Soulet, et al.
Brain Research Bulletin (2023) Vol. 199, pp. 110668-110668
Open Access | Times Cited: 12
Neutrophil extracellular traps in central nervous system (CNS) diseases
Bo‐Zong Shao, Jingjing Jiang, Yicheng Zhao, et al.
PeerJ (2024) Vol. 12, pp. e16465-e16465
Open Access | Times Cited: 4
Parkinson disease therapy: current strategies and future research priorities
Fabrizio Stocchi, Daniele Bravi, Aron Emmi, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 12, pp. 695-707
Closed Access | Times Cited: 4
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD
Stefanie Lerche, Milan Zimmermann, Benjamin Röeben, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases
Evgeniia Lobanova, Yu P. Zhang, Derya Emin, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson’s disease
Hung‐Li Wang, Yi‐Chuan Cheng, Tu‐Hsueh Yeh, et al.
Biochemical Pharmacology (2023) Vol. 212, pp. 115524-115524
Closed Access | Times Cited: 7
NLRP3 mediates the neuroprotective effects of SVHRSP derived from scorpion venom in rotenone-induced experimental Parkinson’s disease model
Yu Zhang, Sheng Li, Liyan Hou, et al.
Journal of Ethnopharmacology (2023) Vol. 312, pp. 116497-116497
Closed Access | Times Cited: 7
Lack of genetic evidence for NLRP3 inflammasome involvement in Parkinson’s disease pathogenesis
Konstantin Senkevich, L W Liu, Chelsea X. Alvarado, et al.
npj Parkinson s Disease (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Insights into the structure of NLR family member X1: Paving the way for innovative drug discovery
Shannon Jewell, Thanh Binh Nguyen, David B. Ascher, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3506-3513
Open Access | Times Cited: 1
Aurantio-obtusin Alleviates Dry Eye Disease by Targeting NF-κB/NLRP3 Signaling in Rodent Models
Dan Zhu, Na Zheng, Kebin Deng, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 2, pp. 1-14
Closed Access | Times Cited: 2
Clinical Trial Highlights: Anti-Inflammatory and Immunomodulatory Agents
Bina Patel, Julia C. Greenland, Caroline H. Williams‐Gray
Journal of Parkinson s Disease (2024), pp. 1-18
Open Access
Inosine exerts dopaminergic neuroprotective effects via mitigation of NLRP3 inflammasome activation
Khanal Shristi, Eun‐Joo Shin, Chang Jae Yoo, et al.
Neuropharmacology (2024), pp. 110278-110278
Closed Access
Linking Immune Activation and Parkinson’s Disease
Bastiaan R. Bloem, Patrik Brundin, Ashley S. Harms, et al.
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S1-S3
Open Access | Times Cited: 3
Microglia-Mediated Neuroinflammation in Parkinson’s Disease
Vila Bulls
Science Insights (2023) Vol. 42, Iss. 6, pp. 963-968
Open Access
Editorial: Physiology and pathology of neuroglia
Daniel Reyes‐Haro, Alejandro López‐Juárez, Adrián Rodríguez‐Contreras
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access
Genetics of NLRP3 suggests lack of involvement and inefficient druggability in Parkinson’s disease
Konstantin Senkevich, Lang Liu, Chelsea X. Alvarado, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Exploring Inflammasome Complex as a Therapeutic Approach in Inflammatory Diseases
Sharmim Sultana, Thanh Doan Viet, Tasmiha Amin, et al.
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 789-818
Open Access
Page 1 - Next Page

Scroll to top